Physician

Anjan Tibrewala, M.D.

According to 2025 Medicare claims, Anjan Tibrewala, M.D. (NPI: 1730474685) practices advanced heart failure and transplant cardiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60190-1295. Tibrewala is affiliated with the IRCCO (ACO ID: A2619), Northwestern Medicine Physician Network ACO (ACO ID: A2620), and Northwestern Medicine Health Network ACO LLC (ACO ID: A5444), participating under the MSSP model.

Tibrewala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 562 traditional Medicare patients, billed 1,923 HCPCS/CPT codes, and received $157,769 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 5,590 prescription claims across 543 beneficiaries totaling $3,583,826 in drug costs, led by Vyndamax (Tafamidis). DME data shows 441 claims. Open Payments data shows 23 records totaling $45,705. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $39,326 to $157,769. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,445 to $3,583,826. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,353 to $11,278.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$83K$165K2015 Medicare payment: $39,326 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,340 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,462 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $53,796 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $128,890 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $137,215 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $165,218 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $147,778 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $157,769 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015167396$39,326
2016N/RN/RN/R
20171818$2,340
20181212$1,462
2019202539$53,796
20203291,299$128,890
20214571,416$137,215
20224901,663$165,218
20234661,574$147,778
20245621,923$157,769

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8M$3.6M2015 Drug cost: $3,445 (USD; Tot_Drug_Cst)2016 Drug cost: $4,306 (USD; Tot_Drug_Cst)2017 Drug cost: $2,303 (USD; Tot_Drug_Cst)2018 Drug cost: $4,458 (USD; Tot_Drug_Cst)2019 Drug cost: $15,687 (USD; Tot_Drug_Cst)2020 Drug cost: $307,565 (USD; Tot_Drug_Cst)2021 Drug cost: $1,011,595 (USD; Tot_Drug_Cst)2022 Drug cost: $1,859,061 (USD; Tot_Drug_Cst)2023 Drug cost: $2,385,063 (USD; Tot_Drug_Cst)2024 Drug cost: $3,583,826 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201527101$3,445
20161449$4,306
20172676$2,303
20181874$4,458
201952139$15,687
20201711,311$307,565
20212882,681$1,011,595
20223653,908$1,859,061
20234374,760$2,385,063
20245435,590$3,583,826

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.2K$12K2015 Medicare payment: $306 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,219 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,820 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,008 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $8,564 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $12,394 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$306
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R68$2,219
2021N/R119$5,820
2022N/R152$3,008
2023N/R267$8,564
202452441$12,394

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more127167$137
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes102246$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more168196$96
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's253318$14
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report125130$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyndamaxTafamidis511,530$1,135,714
EntrestoSacubitril/Valsartan50132,277$653,409
JardianceEmpagliflozin43229,288$554,537
VyndaqelTafamidis Meglumine13630$466,585
EliquisApixaban19713,219$249,053

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1250Injection, dobutamine hydrochloride, per 250 mgNN/R25$2,645
A4222Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)NN/R25$2,328
J7507Tacrolimus, immediate release, oral, 1 mgN18136$2,298
J7520Sirolimus, oral, 1 mgNN/R25$1,541
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodN16114$1,442

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$13,031Boehringer Ingelheim Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$32,674AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anjan Tibrewala, M.D.?

Tedicare shows public-source Medicare data for Anjan Tibrewala, M.D. (NPI 1730474685), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anjan Tibrewala, M.D. have ACO affiliation data?

Anjan Tibrewala, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620), and Northwestern Medicine Health Network ACO LLC (MSSP, ACO ID A5444).

What billing organization is linked to Anjan Tibrewala, M.D.?

Anjan Tibrewala, M.D. is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Anjan Tibrewala, M.D. have Open Payments data?

Anjan Tibrewala, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.